# Safety and Efficacy of Botulinum Toxin A in Patients With Posttraumatic Headache

> **NCT06839118** · PHASE3 · RECRUITING · sponsor: **Danish Headache Center** · enrollment: 80 (estimated)

## Conditions studied

- Posttraumatic Headache

## Interventions

- **DRUG:** Botox 200 UNT Injection

## Key facts

- **NCT ID:** NCT06839118
- **Lead sponsor:** Danish Headache Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-10
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06839118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06839118, "Safety and Efficacy of Botulinum Toxin A in Patients With Posttraumatic Headache". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06839118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*